These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 10785223)
1. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism. Pigny P; Cortet-Rudelli C; Decanter C; Deroubaix D; Soudan B; Duhamel A; Dewailly D Fertil Steril; 2000 May; 73(5):972-7. PubMed ID: 10785223 [TBL] [Abstract][Full Text] [Related]
2. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome. Cortet-Rudelli C; Pigny P; Decanter C; Leroy M; Maunoury-Lefebvre C; Thomas-Desrousseaux P; Dewailly D Fertil Steril; 2002 Feb; 77(2):281-7. PubMed ID: 11821084 [TBL] [Abstract][Full Text] [Related]
3. High serum concentration of total inhibin in polycystic ovary syndrome. Tsigkou A; Luisi S; De Leo V; Patton L; Gambineri A; Reis FM; Pasquali R; Petraglia F Fertil Steril; 2008 Nov; 90(5):1859-63. PubMed ID: 18423626 [TBL] [Abstract][Full Text] [Related]
4. Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B. Chu MC; Carmina E; Wang J; Lobo RA Fertil Steril; 2005 Dec; 84(6):1685-8. PubMed ID: 16359965 [TBL] [Abstract][Full Text] [Related]
6. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325 [TBL] [Abstract][Full Text] [Related]
7. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Holte J; Bergh T; Gennarelli G; Wide L Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458 [TBL] [Abstract][Full Text] [Related]
8. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism. Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105 [TBL] [Abstract][Full Text] [Related]
9. Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone. Welt CK; Taylor AE; Martin KA; Hall JE J Clin Endocrinol Metab; 2002 Dec; 87(12):5559-65. PubMed ID: 12466353 [TBL] [Abstract][Full Text] [Related]
10. Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome. Wachs DS; Coffler MS; Malcom PJ; Shimasaki S; Chang RJ J Clin Endocrinol Metab; 2008 May; 93(5):1827-33. PubMed ID: 18285408 [TBL] [Abstract][Full Text] [Related]
11. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome. Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303 [TBL] [Abstract][Full Text] [Related]
12. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. Welt CK; Taylor AE; Fox J; Messerlian GM; Adams JM; Schneyer AL J Clin Endocrinol Metab; 2005 Oct; 90(10):5582-7. PubMed ID: 16030174 [TBL] [Abstract][Full Text] [Related]
13. Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility. Laven JS; Imani B; Eijkemans MJ; de Jong FH; Fauser BC Hum Reprod; 2001 Jul; 16(7):1359-64. PubMed ID: 11425813 [TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results. Yetim A; Yetim Ç; Baş F; Erol OB; Çığ G; Uçar A; Darendeliler F J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):288-97. PubMed ID: 27125339 [TBL] [Abstract][Full Text] [Related]
15. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Li X; Lin JF Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817 [TBL] [Abstract][Full Text] [Related]
16. [Serum inhibin B in polycystic ovary syndrome as a potential marker of ovarian dysfunction]. Cetković A Srp Arh Celok Lek; 2008; 136(7-8):379-83. PubMed ID: 18959173 [TBL] [Abstract][Full Text] [Related]
17. Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome. Wu X; Sallinen K; Zhou S; Su Y; Pöllänen P; Erkkola R Fertil Steril; 2000 Apr; 73(4):730-4. PubMed ID: 10731533 [TBL] [Abstract][Full Text] [Related]
18. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents. Li L; Chen X; He Z; Zhao X; Huang L; Yang D J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573 [TBL] [Abstract][Full Text] [Related]
19. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome. Eldar-Geva T; Spitz IM; Groome NP; Margalioth EJ; Homburg R Hum Reprod; 2001 Dec; 16(12):2552-6. PubMed ID: 11726573 [TBL] [Abstract][Full Text] [Related]
20. Serum inhibin pro alphaC in infertile men. Fujisawa M; Yamazaki I; Dobashi M; Okada H; Kamidono S Arch Androl; 2001; 47(3):191-4. PubMed ID: 11695842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]